Manulife (Manufacturers Life Insurance)’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-28,825	Closed	-$12.5K	–	3103
2023 Q1	$12.5K	Hold	28,825	–	–	﹤0.01%	2921
2022 Q4	$34K	Buy	+28,825	New	+$46.9K	﹤0.01%	2934

Other funds holding GRNA

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

CGC

Continental Grain Company New York $448M AUM 6.81% 1-Year Est. Return

TCM

Tao Capital Management San Francisco, California $119M AUM 87.46% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $533M AUM 65.58% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s GRNA Position: Q2 2023 in Review

Manulife (Manufacturers Life Insurance) sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q2 2023, closing a stake of 28,825 shares — an estimated $12.5K sold.

Manulife (Manufacturers Life Insurance) first reported a position in GRNA in Q4 2022 and held it in 2 quarters. The position peaked at $34K in Q4 2022. 48 funds tracked by Wall St. Rank hold GRNA as of Q2 2023.

Manulife (Manufacturers Life Insurance) reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q2 2023 after selling out during the quarter.
Manulife (Manufacturers Life Insurance) sold 28,825 GreenLight Biosciences Holdings, PBC Common Stock shares in Q2 2023, an estimated $12.5K.
Manulife (Manufacturers Life Insurance) first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q4 2022 and held it in 2 quarters.
Manulife (Manufacturers Life Insurance)'s GreenLight Biosciences Holdings, PBC Common Stock position peaked at $34K in Q4 2022.
48 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q2 2023.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2023, filed 11 Aug 2023.